AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 21795455
Drug: 0.08 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.08 mg/kg metreleptin (n = 11)
Trial: 21795455
Drug: 0.01, 0.1,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.01, 0.1, and 0.3 mg/kg metreleptin in both fed and fasting conditions for 1 and 3 d
Trial: 17453095
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of one percent phenol and one percent menthol, twice a day for six weeks
Trial: 11212050
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine with naloxone (0.208 microg x kg(‐1) x hr(‐1))
Trial: 11212050
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine without naloxone (control group)
Trial: 11212050
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine with naloxone
Trial: 9390113
Drug: 0.04 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.04 mg/kg dexamethasone
Trial: 9390113
Drug: 1.0 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mg/kg dexamethasone
Trial: 7816418
Drug: 0.1 mg
RxNorm normalized name: biotin 0.1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg digitoxin per day
Trial: 23465178
Drug: Follow-up testing
RxNorm normalized name: Q-Up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Follow-up testing after a PSA level result of >10 ng/mL
Trial: 23465178
Drug: Referral to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Referral to a urologist after a PSA level result of >4 ng/mL
Trial: 21349239
Drug: Citalopram 40
RxNorm normalized name: citalopram 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram 40 mg once daily plus pipamperone 5 mg twice daily (PipCit)
Trial: 19916992
Drug: Normal dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal dose of nelfinavir (1250 mg q12h for 3.5 days)
Trial: 19916992
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose of nelfinavir (1250 mg q12h for 3 days and single dose of 3125 mg on day 4)
Trial: 17299467
Drug: Test yoghurt
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test yoghurt containing GOS (12 g/day), prunes (12 g/day) and linseed (6 g/day)
Trial: 14618095
Drug: Morning dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morning dosing of amlodipine (5 mg initially, titrated to 10 mg if diastolic BP >= 90 mm Hg)
Trial: 14618095
Drug: Morning dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morning dosing of amlodipine
Trial: 11009051
Drug: Normal-strength grapefruit
RxNorm normalized name: GRAPEFRUIT
DrugBank: Grapefruit (DB10534)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal-strength grapefruit juice (200 ml)
Trial: 11009051
Drug: Double-strength grapefruit
RxNorm normalized name: GRAPEFRUIT
DrugBank: Grapefruit (DB10534)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double-strength grapefruit juice (200 ml)
Trial: 11009051
Drug: Multiple-dose double-strength
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple-dose double-strength grapefruit juice (three times daily)
Trial: 1395911
Drug: Lovastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lovastatin (20 to 80 mg daily for 3 months)
Trial: 6118074
Drug: Pancuronium 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pancuronium 0.1 mg/kg
Trial: 2869713
Drug: Pancuronium 0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pancuronium 0.05 mg/kg and 0.08 mg/kg
Trial: 29110109
Drug: MRI-based Kellgren
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MRI-based Kellgren and Lawrence (K&L) grading
Trial: 20586860
Drug: Sofalcone (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sofalcone (300 mg/day)
Trial: 8931684
Drug: Dolasetron mesylate
RxNorm normalized name: Dolasetron Mesylate
DrugBank: Dolasetron (DB00757)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dolasetron mesylate 1.8 mg/kg
Trial: 8708713
Drug: Dolasetron mesylate
RxNorm normalized name: Dolasetron Mesylate
DrugBank: Dolasetron (DB00757)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dolasetron mesylate 2.4 mg/kg
Trial: 26191966
Drug: Occupational therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occupational therapy intervention plus guideline-level care
Trial: 20203161
Drug: Methylprednisolone 500
RxNorm normalized name: methylprednisolone 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone 500 mg intravenously
Trial: 17095134
Drug: Hypertonic saline
RxNorm normalized name: ENTSOL Hypertonic Saline Nasal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypertonic saline (HHS) 2 ml/kg/10 min (7.2% NaCl with 6% hydroxy ethyl starch 200,000/0.5)
Trial: 10506878
Drug: Pristinamycin, 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pristinamycin, 1 g b.i.d.
Trial: 10506878
Drug: Amoxicillin/clavulanic acid,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanic acid, 500 mg x 4/d
Trial: 3095082
Drug: Ritanserin 10
RxNorm normalized name: ketanserin
DrugBank: Ketanserin (DB12465)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritanserin 10 mg
Trial: 24016559
Drug: Lidocaine and
RxNorm normalized name: Lidocaine and Tetracaine
DrugBank: Tetracaine (DB09085)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lidocaine and hormone
Trial: 24016559
Drug: Ginaton and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginaton and hormone
Trial: 19141586
Drug: Spironolactone (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone (200 mg)
Trial: 19141586
Drug: RU38486 (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RU38486 (400 mg)
Trial: 19141586
Drug: Combined spironolactone
RxNorm normalized name: Spironolactone
DrugBank: Spironolactone (DB00421)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Combined spironolactone (200 mg) + RU38486 (400 mg)
Trial: 10942064
Drug: CMB-401 (dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CMB-401 (dosing commenced at 2 mg/m2 and progressed to 16 mg/m2 over seven cohorts)
Trial: 8843892
Drug: Pravastatin (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin (15 mg) for 12 months
Trial: 6565475
Drug: Single-dose amoxicillin
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single-dose amoxicillin
Trial: 6565475
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy for ten days
Trial: 15625212
Drug: Sustained-release lithium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained-release lithium carbonate
Trial: 12407605
Drug: High-dose AF0144
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose AF0144 (2.7 g/kg)
Trial: 12407605
Drug: Low-dose AF0144
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose AF0144 (1.8 g/kg)
Trial: 27144828
Drug: Stem cells
RxNorm normalized name: Stem cells, apheresis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stem cells cultured on β‐TCP in combination with rh‐PDGF‐BB
Trial: 24080653
Drug: motavizumab‐YTE (0.3,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: motavizumab‐YTE (0.3, 3, 15, or 30 mg/kg)
Trial: 21068692
Drug: Hib-MenC-TT vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hib-MenC-TT vaccine
Trial: 14768922
Drug: Bupivacaine 0.125%
RxNorm normalized name: BUPIVACAINE 0.125%/NS INJ 250ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.125% with sufentanil 0.75 microg mL(‐1)
Trial: 14768922
Drug: Ropivacaine 0.125%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 0.125% with sufentanil 0.75 microg mL(‐1)
Trial: 2788001
Drug: Transcutaneous electrical
RxNorm normalized name: Transcutaneous Electrical Nerve Stimulators (TENS Units) MISCELL EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transcutaneous electrical nerve stimulation with naloxone (50 mg)
Trial: 358815
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg intravenous digoxin
Trial: 358815
Drug: 1.0 mg
RxNorm normalized name: HYDROCORTISONE BUTYRATE 1.0 mg in 1 g TOPICAL CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mg intravenous digoxin
Trial: 358815
Drug: 1.5 mg
RxNorm normalized name: boron 1.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg intravenous digoxin
Trial: 28494047
Drug: Immediately Loaded
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediately Loaded Implants (IL)
Trial: 28494047
Drug: Delayed Loaded
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed Loaded Nonsubmerged Implants (NS)
Trial: 28494047
Drug: Delayed Loaded
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed Loaded Submerged Implants (SI)
Trial: 23849964
Drug: Control Group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control Group (chronic statin therapy without reloading)
Trial: 16448524
Drug: Glimepiride (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glimepiride (2 mg/day) plus metformin (1500 mg/day)
Trial: 16448524
Drug: Rosiglitazone (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosiglitazone (4 mg/day) plus metformin (1500 mg/day)
Trial: 10697061
Drug: Oseltamivir 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oseltamivir 150 mg twice daily
Trial: 8222517
Drug: 5% glucose
RxNorm normalized name: Dextrose/Water 5% Oral Solution [ENFAMIL 5% GLUCOSE IN WATER]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% glucose polymer solution (272 +/- 1.1 mosmol/kg)
Trial: 8222517
Drug: 7.5% glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5% glucose polymer solution (277 +/- 2.0 mosmol/kg)
Trial: 8222517
Drug: 1.36% glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.36% glucose solution (339 +/- 1.9 mosmol/kg)
Trial: 8222517
Drug: 2.27% glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.27% glucose solution (393 +/- 3.2 mosmol/kg)
Trial: 8222517
Drug: 10% glucose
RxNorm normalized name: Dextrose 10% Oral Solution [SIMILAC 10% GLUCOSE WATER]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% glucose polymer solution (284 +/- 2.0 mosmol/kg)
Trial: 8222517
Drug: 3.86% glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.86% glucose solution (482 +/- 1.6 mosmol/kg)
Trial: 8222517
Drug: 7.5% glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5% glucose polymer solution with 0.35% glucose
Trial: 30515390
Drug: Coconut water
RxNorm normalized name: COCONUT WATER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coconut water (2L daily for 4 days)
Trial: 16083628
Drug: Vitamin treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin treatment (group A, n = 18, folic acid 5 mg/d, vitamin B(6) 50 mg/d, B(12) 1000 microg/d)
Trial: 12064916
Drug: Deferiprone (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deferiprone (75 mg/kg/day)
Trial: 12064916
Drug: Deferoxamine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deferoxamine (50 mg/kg/day)
Trial: 9793811
Drug: Clonidine 5
RxNorm normalized name: apraclonidine 5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine 5 mcg/kg (C5)
Trial: 9793811
Drug: Clonidine 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine 2.5 mcg/kg (C2.5)
Trial: 9793811
Drug: Diazepam 100
RxNorm normalized name: diazepam 100 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam 100 mcg/kg (D)
Trial: 7543785
Drug: Fotemustine (FM)
DrugBank: Fotemustine (DB04106)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fotemustine (FM) 100 mg/m2 on days 1 + 8 + 15, followed by maintenance courses (q3w)
Trial: 2877570
Drug: Famotidine 40
RxNorm normalized name: famotidine 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Famotidine 40 mg at bedtime
Trial: 2696659
Drug: Ranitidine 300
RxNorm normalized name: ranitidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 300 mg single dose
Trial: 825895
Drug: 1000 mug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mug TRH (thyrotropin releasing hormone) by slow, continuous infusion over 4 hours
Trial: 28691141
Drug: Vinpocetine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vinpocetine (30 mg per day intravenously for 14 consecutive days)
Trial: 20121770
Drug: 0.11 ml.mm(‐2)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.11 ml.mm(‐2) cross‐sectional nerve area with mepivacaine 1% (low volume)
Trial: 20121770
Drug: 0.4 ml.mm(‐2)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4 ml.mm(‐2) cross‐sectional nerve area with mepivacaine 1% (high volume)
Trial: 6121043
Drug: Intravenous injection
RxNorm normalized name: Meta Trace FDG, intravenous injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous injection of lorazepam (2 mg)
Trial: 6121043
Drug: Intramuscular injection
RxNorm normalized name: rabies, intramuscular injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injection of lorazepam (2 mg)
Trial: 6121043
Drug: Sublingual lorazepam
RxNorm normalized name: Lorazepam
DrugBank: Lorazepam (DB00186)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual lorazepam (2 mg) from oral tablets
Trial: 6121043
Drug: Sublingual lorazepam
RxNorm normalized name: Lorazepam
DrugBank: Lorazepam (DB00186)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual lorazepam (2 mg) from specially formulated tablets
Trial: 6121043
Drug: Intramuscular, oral,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular, oral, and sublingual lorazepam (2 mg)
Trial: 24756903
Drug: Rituximab (RTX)
RxNorm normalized name: Rituximab
DrugBank: Rituximab (DB00073)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Rituximab (RTX) therapy
Trial: 17445955
Drug: HPV-16 vaccine
RxNorm normalized name: HPV 16 E7/HSP65 vaccine
DrugBank: Verpasep caltespen (DB04959)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HPV-16 vaccine (three-dose regimen)
Trial: 12236023
Drug: SB-LOT (90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SB-LOT (90 mg coumarin and 540 mg troxerutin per day)
Trial: 2405915
Drug: Vasopressin nasal
RxNorm normalized name: Vasopressin
DrugBank: Vasopressin (DB00067)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vasopressin nasal spray administered q.i.d. from the first through the fifth ECT
Trial: 9569075
Drug: Oral prednisolone
RxNorm normalized name: prednisolone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prednisolone (OP)
Trial: 25406226
Drug: Written materials
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Written materials plus nicotine replacement therapy (NRT)
Trial: 24942849
Drug: Automated bolus
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Automated bolus delivery of 0.2% ropivacaine (4 mL) with PRN boluses (5 mL, lockout 30 min)
Trial: 24942849
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of 0.2% ropivacaine (4 mL/h) with PRN boluses (5 mL, lockout 30 min)
Trial: 15220019
Drug: Fixed-combination dorzolamide/timolol,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-combination dorzolamide/timolol, 1 drop in the affected eye BID (morning and evening)
Trial: 9353612
Drug: Transcutaneous electrotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transcutaneous electrotherapy (H-Wave machine, pulse width 4 ms, 25-35 V, > or = 2 Hz, 30 min daily for 4 weeks)
Trial: 9353612
Drug: Transcutaneous electrotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transcutaneous electrotherapy (after sham treatment)
Trial: 8144852
Drug: Metyrapone (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metyrapone (750 mg orally at 08:00 h on day 1 and at 4 hourly intervals over a 24-h period)
Trial: 8144852
Drug: Hydrocortisone (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocortisone (20 mg tablet)
Trial: 3018023
Drug: Continuous intravenous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous intravenous infusion of 250 micrograms Cosyntropin (ACTH‐(1‐24))
Trial: 3018023
Drug: Bolus injection
RxNorm normalized name: SET,INFUSION,BOLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus injection of 250 micrograms Cosyntropin (ACTH‐(1‐24))
Trial: 31774626
Drug: Intranasal delivery
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal delivery of human umbilical cord Wharton's jelly mesenchymal stromal cells (500,000 cells per 20 μL)
Trial: 31774626
Drug: Intranasal delivery
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal delivery of human umbilical cord Wharton's jelly mesenchymal stromal cells
Trial: 30683494
Drug: Conventional anti-inflammatory
RxNorm normalized name: Surpass Anti-Inflammatory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional anti-inflammatory treatment plus colchicine for 3 months
Trial: 30683494
Drug: Conventional anti-inflammatory
RxNorm normalized name: Surpass Anti-Inflammatory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional anti-inflammatory treatment only
Trial: 26181174
Drug: Estrogen plus
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen plus progestin (E+P) - 0.625 mg/d conjugated equine estrogens plus 2.5 mg/d medroxyprogesterone acetate
Trial: 26181174
Drug: Estrogen alone
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen alone - 0.625 mg/d conjugated equine estrogens
Trial: 19414982
Drug: Oral hypoglycemic
RxNorm normalized name: ORAL HYPOGLYCEMIC AGENTS,ORAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral hypoglycemic agent (OHA)
Trial: 14737055
Drug: G‐CSF at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G‐CSF at 5 Kg/kg for established febrile neutropenia (Group A)
Trial: 14737055
Drug: G‐CSF at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G‐CSF at 263 Kg/day if ANC was 1500/microl or less (Group B)
Trial: 8032072
Drug: Lower dose
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower dose (0.4 mg/kg)
Trial: 8032072
Drug: Higher dose
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher dose (0.6 mg/kg)
Trial: 3689065
Drug: Ranitidine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine (150 mg twice daily) plus aspirin (650 mg four times daily)
Trial: 3689065
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus aspirin (650 mg four times daily)
Trial: 26301448
Drug: Risperidone monotherapy
RxNorm normalized name: Risperidone
DrugBank: Risperidone (DB00734)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Risperidone monotherapy
Trial: 29482256
Drug: Adjunctive aripiprazole
RxNorm normalized name: Aripiprazole
DrugBank: Aripiprazole (DB01238)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Adjunctive aripiprazole (5mg and 10mg)
Trial: 27302126
Drug: Fresh frozen
RxNorm normalized name: Fresh frozen plasma
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fresh frozen plasma (FFP) 20 mL/kg intravenous
Trial: 27302126
Drug: Prothrombin complex
RxNorm normalized name: prothrombin complex
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prothrombin complex concentrate (PCC) 30 IU/kg intravenous
Trial: 18940711
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (a rest hour)
Trial: 16161468
Drug: Placebo-control compound
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo-control compound
Trial: 1617799
Drug: Insulin alone
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin alone at 0 minutes
Trial: 1617799
Drug: Insulin at
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin at 0 minutes and arginine at 0-30 minutes
Trial: 29364033
Drug: Cupping therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cupping therapy (7-minute treatment with four 2-in cups on trigger points in hamstring)
Trial: 1939676
Drug: Supportive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supportive therapy (Control)
Trial: 22853619
Drug: Chemotherapy combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy combined with Traditional Chinese Medicine (TCM) for four cycles, administered every 3 weeks.
Trial: 22853619
Drug: Chemotherapy alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy alone (placebo) for four cycles, administered every 3 weeks.
Trial: 17971598
Drug: Prophylactic cranial
RxNorm normalized name: geranial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic cranial irradiation (PCI) 30 Gy; 2 Gy daily fractions
Trial: 7928814
Drug: Cefprozil (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefprozil (20 mg/kg/day bd)
Trial: 7928814
Drug: Amoxycillin/clavulanate (13.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxycillin/clavulanate (13.3 mg/kg/day tid)
Trial: 2813153
Drug: Acetaminophen 600
RxNorm normalized name: acetaminophen 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen 600 mg with Codeine 60 mg
Trial: 1096923
Drug: Azaribine at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azaribine at 200 mg/kg a day
Trial: 1096923
Drug: Azaribine at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azaribine at 125 mg/kg a day